Adegboyega K Oyelere

USPTO Granted Patents = 19 (Patent Applications = 11)

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 2 (Patent Applications = 4)

Average Co-Inventor Count = 4.4

ph-index = 5

Forward Citations = 101(Granted Patents)

Location History:

New Haven, CT (US) (2010 - 2013)
Hamden, CT (US) (2005 - 2014)
Marietta, GA (US) (2010 - 2024)

Company Filing History:

9 out of 17

Rib-x Pharmaceuticals, Inc.

patents

6 out of 2,088

Georgia Tech Research Corporation

Melinta Therapeutics, Inc.

patents

5. 1 out of 4

Clark Atlanta University, Inc.

patents

6. 1 out of 832,880

Other

patents

where one patent can have more than one assignee

Years Active: 2005-2025

Loading Chart...

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12324803 - 3-(hydroxy)-pyridin-4(1H)-one compounds and methods of making and using the same (2025-06-10),

2. 12084418 - Small molecule inhibitors of G(alpha)i2 protein and uses thereof (2024-09-10),

3. 11654137 - 3-(hydroxy)-pyridin-4(1H)-one compounds and methods of making and using the same (2023-05-23),

4. 9550783 - Biaryl heterocyclic compounds and methods of making and using the same (2017-01-24),

5. 9139565 - Histone deacetylase (HDAC) inhibitors targeting prostate tumors and methods of making and using thereof (2015-09-22),

6. 8912150 - Ribosome structure and protein synthesis inhibitors (2014-12-16),

7. 8871728 - Non-peptide macrocyclic histone deacetylese (HDAC) inhibitors and methods of making and using thereof (2014-10-28),

8. 8841263 - Macrocyclic compounds and methods of making and using the same (2014-09-23),

9. 8470990 - Ribosome structure and protein synthesis inhibitors (2013-06-25),

10. 8202843 - Macrocyclic compounds and methods of making and using the same (2012-06-19),

11. 8188054 - Non-peptide macrocyclic histone deacetylase (HDAC) inhibitors and methods of making and using thereof (2012-05-29),

12. 7705026 - Biaryl heterocyclic compounds and methods of making and using the same (2010-04-27),

13. 7666849 - Ribosome structure and protein synthesis inhibitors (2010-02-23),

14. 7456206 - Biaryl heterocyclic compounds and methods of making and using the same (2008-11-25),

15. 7335753 - Bifunctional heterocyclic compounds and methods of making and using same (2008-02-26),

Certainly! Here's the article about inventor Adegboyega K. Oyelere:

Title: Exploring the Innovative Mind of Adegboyega K. Oyelere

Introduction:

Adegboyega K. Oyelere, a prolific inventor based in Marietta, GA (US), has left an indelible mark on the world of patents with his groundbreaking discoveries. With an impressive portfolio of 17 patents, Oyelere is celebrated for his contributions to the fields of chemistry and pharmaceuticals.

Latest Patents:

Oyelere's latest patents showcase his expertise in developing cutting-edge compounds with diverse applications. His inventions include 3-(hydroxy)-pyridin-4(1H)-one compounds that inhibit histone lysine demethylases, as well as biaryl heterocyclic compounds with anti-infective, anti-proliferative, anti-inflammatory, and prokinetic properties.

Career Highlights:

Having worked at esteemed organizations like Rib-x Pharmaceuticals, Inc. and Georgia Tech Research Corporation, Oyelere has honed his skills and expertise in translational research. His patents stand as a testament to his relentless pursuit of innovation in the pharmaceutical industry.

Collaborations:

Throughout his career, Oyelere has collaborated with esteemed colleagues such as Rongliang Lou and Deping Wang. Together, they have pushed the boundaries of scientific discovery and paved the way for novel treatment modalities.

Conclusion:

In conclusion, Adegboyega K. Oyelere's contributions to the world of inventions and patents have been nothing short of remarkable. His inventive spirit and collaborative efforts continue to inspire future generations of innovators in the realm of pharmaceutical sciences.

If you have any more specific requests or need further information about Adegboyega K. Oyelere or any other inventors, feel free to ask!

This text is generated by artificial intelligence and may not be accurate.